Chinese Journal of Pharmacovigilance ›› 2020, Vol. 17 ›› Issue (8): 455-460.
DOI: 10.19803/j.1672-8629.2020.08.02

Previous Articles     Next Articles

Mutagenic Risk Evaluation of Monanthone with Emodin Type

WEN Hairuo1, WANG Yanan1, YANG Ying1, ZHAO Tingting1, MA Shuangcheng2, WANG Qi2,*   

  1. 1National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Key Laboratory of Beijing for Nonclinical Safety Evaluation Research of Drugs, Beijing 100176, China;
    2Institute for Control of Chinese Traditional Medicine and Ethnic Medicine, National Institutes for Food and Drug Control, Beijing 100050, China
  • Received:2020-07-31 Revised:2020-07-31 Online:2020-08-15 Published:2020-07-31
  • Supported by:
    国家自然科学基金资助项目(81503347, 81503068); 国家十三五“重大新药创制”专项(2018ZX09201017)

Abstract: Objective To evaluate the gene mutations caused by the potential genotoxicity of monanthone with emodin type by means of the miniAmes test and in vitro Pig-a gene mutation test. Methods The miniAmes test involved the control group (DMSO), monanthone with emodin type (0.6, 1.1, 2.3, 4.5, 9 μg/well), and positive group. Salmonella typhimurium TA97, TA98, TA100, TA102, TA1535, TA1537 bacterial reverse mutation assay based on 6-well plate culture was carried out in E. coli WP2 uvrA under the conditions of -S9 and S9, respectively. The number of mutant colonies was counted after 48 h. The In vitro Pig-a gene mutation test involved L5178Y cells that were used as the system, and metabolic conditions without S9: control group (1% DMSO), positive agent (EMS 500 μg/mL), and monanthone with emodin type (0.2 μg/mL,0.39 μg/mL,0.78 μg/mL,1.56 μg/mL).After the test object was treated for 4 h, the test substance and culture were removed. After 24 h, the cells were counted and expressed for 8 days. The cell density during the expression period was maintained at 1×106~2×106 cells/mL. After the expression was terminated, antibody incubation flow detection was performed. Metabolic conditions with S9: control group (1% DMSO), positive agent (B(a)P 5 μg/mL), and monoterpene ketone (0.2 μg/mL,0.39 μg/mL,0.78 μg/mL,1.56 μg/mL). After the test object was treated for 4 h, the test material was removed and cultured, and counted 24 hours later for 8 days. The cell density during the expression period was 1×106~2×106 cells/mL. After the expression was over, the antibody incubation flow assay was performed. Results In the Ames test, the number of colonies of TA97 and TA1537 reverting mutants induced by monanthone with emodin type increased compared with the negative control group under the metabolic activation conditions without S9. Upon metabolic activation with S9, the number of colonies of TA1537 reverting mutants induced by monanthone with emodin type increased compared with the negative control group. The rate of increase was more than two or three times that of the negative control group, and there was dose-related change in the above results. In vitro Pig-a gene mutation test showed that under metabolic activation conditions without S9, the concentration of monanthone with emodin type exceeded 0.78 μg/mL, and the mutation frequency of Pig-a gene was significantly different from that of the vehicle control group (P <0.01) with a dose correlation. Conclusion Under the conditions described in this study, monanthone with emodin type has the risk of gene mutation.

Key words: Polygonummultiflorum Thunb, monanthone with emodin type, gene mutation, genotoxicity, Ames test, in vitro Pig-a gene mutation

CLC Number: